Sinon Corporation, a leading player in the biotechnology and pharmaceutical industry, is headquartered in Taiwan (TW). Founded in 1995, the company has established a strong presence in the Asia-Pacific region, focusing on the development and manufacturing of high-quality biopharmaceuticals and medical devices. Sinon is renowned for its innovative core products, including advanced drug delivery systems and diagnostic reagents, which are distinguished by their precision and reliability. Over the years, Sinon has achieved significant milestones, positioning itself as a trusted partner in healthcare solutions. With a commitment to research and development, Sinon Corporation continues to enhance its market position, contributing to advancements in medical technology and patient care.
How does Sinon Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Salt and Mineral Mining industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sinon Corporation's score of 23 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Sinon Corporation reported total carbon emissions of approximately 33,197,000 kg CO2e. This figure comprises 3,061,000 kg CO2e from Scope 1 emissions and 30,136,000 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Comparatively, in 2022, Sinon Corporation's total emissions were approximately 34,487,000 kg CO2e, with Scope 1 emissions at 1,677,000 kg CO2e and Scope 2 emissions at 32,810,000 kg CO2e. This indicates a reduction of about 1,290,000 kg CO2e in total emissions from 2022 to 2023. Currently, Sinon Corporation has not established any specific reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of documented reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. Overall, Sinon Corporation's emissions data reflects a commitment to monitoring and reporting its carbon footprint, although further steps may be necessary to enhance its climate commitments and reduction strategies.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 1,677,000 | 0,000,000 |
| Scope 2 | 32,810,000 | 00,000,000 |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sinon Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

